209 related articles for article (PubMed ID: 31364339)
1. Possible clinical indications of ceftobiprole.
Barberán J
Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):29-33. PubMed ID: 31364339
[TBL] [Abstract][Full Text] [Related]
2. Ceftobiprole for the treatment of pneumonia: a European perspective.
Liapikou A; Cillóniz C; Torres A
Drug Des Devel Ther; 2015; 9():4565-72. PubMed ID: 26316697
[TBL] [Abstract][Full Text] [Related]
3. Ceftobiprole: drug evaluation and place in therapy.
Giacobbe DR; De Rosa FG; Del Bono V; Grossi PA; Pea F; Petrosillo N; Rossolini GM; Tascini C; Tumbarello M; Viale P; Bassetti M
Expert Rev Anti Infect Ther; 2019 Sep; 17(9):689-698. PubMed ID: 31553250
[No Abstract] [Full Text] [Related]
4. Ceftobiprole for the treatment of pneumonia.
Cillóniz C; Dominedò C; Garcia-Vidal C; Torres A
Rev Esp Quimioter; 2019 Sep; 32 Suppl 3(Suppl 3):17-23. PubMed ID: 31364337
[TBL] [Abstract][Full Text] [Related]
5. Ceftobiprole medocaril: a review of its use in patients with hospital- or community-acquired pneumonia.
Syed YY
Drugs; 2014 Sep; 74(13):1523-42. PubMed ID: 25117196
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic drug evaluation of ceftobiprole for the treatment of MRSA.
Horn KS; Danziger LH; Rodvold KA; Glowacki RC
Expert Opin Drug Metab Toxicol; 2017 Apr; 13(4):463-472. PubMed ID: 28264613
[TBL] [Abstract][Full Text] [Related]
7. [Antibiotic therapy in elderly patients].
Bellmann-Weiler R; Weiss G
Dtsch Med Wochenschr; 2008 Feb; 133(8):350-3. PubMed ID: 18270915
[No Abstract] [Full Text] [Related]
8. Pharmacokinetic and pharmacodynamics evaluation of ceftobiprole medocaril for the treatment of hospital-acquired pneumonia.
Lagacé-Wiens PR; Rubinstein E
Expert Opin Drug Metab Toxicol; 2013 Jun; 9(6):789-99. PubMed ID: 23590397
[TBL] [Abstract][Full Text] [Related]
9. The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.
Stein GE; Wells EM
Curr Med Res Opin; 2010 Mar; 26(3):571-88. PubMed ID: 20055750
[TBL] [Abstract][Full Text] [Related]
10. Ceftobiprole medocaril in the treatment of hospital-acquired pneumonia.
Scheeren TW
Future Microbiol; 2015; 10(12):1913-28. PubMed ID: 26573022
[TBL] [Abstract][Full Text] [Related]
11. A Phase 3, Randomized, Investigator-blinded Trial Comparing Ceftobiprole With a Standard-of-care Cephalosporin, With or Without Vancomycin, for the Treatment of Pneumonia in Pediatric Patients.
Bosheva M; Gujabidze R; Károly É; Nemeth A; Saulay M; Smart JI; Hamed KA
Pediatr Infect Dis J; 2021 Jun; 40(6):e222-e229. PubMed ID: 33480665
[TBL] [Abstract][Full Text] [Related]
12. Cefoperazone: an analysis of results in the pediatric population from a post-marketing surveillance study in hospitalized patients. The Cefoperazone Collaborative Post-marketing Surveillance Study Group.
Indian J Pediatr; 1998; 65(1):89-98. PubMed ID: 10771951
[TBL] [Abstract][Full Text] [Related]
13. Complicated skin and soft tissue infection.
Dryden MS
J Antimicrob Chemother; 2010 Nov; 65 Suppl 3():iii35-44. PubMed ID: 20876627
[TBL] [Abstract][Full Text] [Related]
14. Ceftaroline fosamil (Teflaro) - a new IV cephalosporin.
Med Lett Drugs Ther; 2011 Jan; 53(1356):5-6. PubMed ID: 21252841
[No Abstract] [Full Text] [Related]
15. [Ceftaroline fosamil, a broad spectrum cephalosporin antibiotic for the treatment of community-acquired pneumonia and complicated skin and skin structure infections].
Nikitin AV
Antibiot Khimioter; 2011; 56(7-8):47-9. PubMed ID: 22359871
[No Abstract] [Full Text] [Related]
16. Pharmacokinetic and pharmacodynamic profile of ceftobiprole.
Lodise TP; Patel N; Renaud-Mutart A; Gorodecky E; Fritsche TR; Jones RN
Diagn Microbiol Infect Dis; 2008 May; 61(1):96-102. PubMed ID: 18384996
[TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics and Dosing of Ceftobiprole Medocaril for the Treatment of Hospital- and Community-Acquired Pneumonia in Different Patient Populations.
Torres A; Mouton JW; Pea F
Clin Pharmacokinet; 2016 Dec; 55(12):1507-1520. PubMed ID: 27272266
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of a possible signal of increased mortality associated with cefepime use.
Kim PW; Wu YT; Cooper C; Rochester G; Valappil T; Wang Y; Kornegay C; Nambiar S
Clin Infect Dis; 2010 Aug; 51(4):381-9. PubMed ID: 20624065
[TBL] [Abstract][Full Text] [Related]
19. [Uncertainties in the therapy of infectious diseases].
Heimann D
Dtsch Med Wochenschr; 2014 Nov; 139 Suppl 3():S82. PubMed ID: 25429535
[No Abstract] [Full Text] [Related]
20. Ceftobiprole medocaril for the treatment of community-acquired pneumonia.
Falcó V; Burgos J; Almirante B
Expert Opin Pharmacother; 2018 Sep; 19(13):1503-1509. PubMed ID: 30198789
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]